Immune system
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
Start here
Thymosin Alpha-1 is a peptide your thymus gland makes naturally to help train and activate immune cells. It is studied for boosting T-cell function 24, supporting recovery from chronic viral infections like hepatitis B and C 46, and reducing infection rates in people with weakened immune systems 3. It is not FDA approved in the US, but it is used in other countries (as Zadaxin) for chronic hepatitis B and as an immune adjuvant, a treatment given to boost the immune response. It is taken as an injection under the skin.
Think of your thymus as a training camp for immune cells. When you're young, it's busy churning out trained T-cells ready to fight infections and cancer. But as you age, your thymus shrinks and produces less of its natural trainer—thymosin. Thymosin Alpha-1 is like bringing in a coach to keep training your immune cells even when your thymus has slowed down. It teaches immature immune cells how to become effective fighters, helps experienced cells work better, and even keeps your immune system from overreacting to things it shouldn't attack.
Thymosin Alpha-1 (Tα1) is a peptide of 28 amino acids that regulates the immune system through several converging routes. It signals through Toll-like receptors (TLR2, TLR9; sensors that detect germs) on dendritic cells and other antigen-presenting cells (immune cells that show threats to T-cells), helping them mature and present threats better. This improves T-cell priming (getting T-cells ready) and differentiation, especially toward Th1 responses (the type that fights virus-infected and abnormal cells). Tα1 raises markers of T-cell precursor maturation, including terminal deoxynucleotidyl transferase (TdT, an enzyme found in young T-cells) in pre-T cells. It increases IL-2 receptor levels on T-cells and boosts production of IL-2, IFN-α and IFN-γ (immune messengers), while adjusting IL-10 and other regulating messengers. Uniquely, Tα1 switches on indoleamine 2,3-dioxygenase (IDO, an enzyme) in dendritic cells. This gives negative feedback (a brake) that prevents too much inflammation and autoimmunity (the immune system attacking the body). That explains why it both boosts and steadies the immune system. The peptide also acts directly on natural killer (NK) cells (immune cells that destroy infected or abnormal cells) and may affect apoptosis (programmed cell death) pathways in tumor cells. It is absorbed quickly (Tmax ~2 hours, the time to peak blood level) and clears fast (half-life (how long it stays active in your body) ~2 hours), so twice-weekly dosing is needed for lasting immune effects.
Evidence check
Some human studies
It has been tested in people, but only in small or early-stage studies. Promising, but not yet proven the way an approved medicine is.
Every numbered marker on this page links to one of the 6 sources at the bottom.
Immune Activation
Directly enhances T-cell and dendritic cell function with extensive clinical validation across thousands of patients
Infection Fighting
In chronic hepatitis B, HBV DNA cleared in 40.6% at 6 months against 9.4% of untreated controls in one randomized trial, though results across trials were mixed. With interferon in hepatitis C, HCV RNA cleared in 65% against 29% on interferon alone.
Immune Balance
Unique ability to boost immunity while preventing harmful overreaction through IDO pathway activation
The most-asked question
The research-reported range is 1.6 mg, twice weekly. Studies used different doses for different situations — find yours:
Chronic hepatitis B, Immune support
1.6 mg
Established clinical dose for thymalfasin (Zadaxin); body-surface-scaled as 900 mcg/m2 46. Phase III chronic hepatitis B trials used 1.6 mg SC twice weekly for 6-12 months 4.
Acute immune support, Adjuvant therapy
1.6 mg daily, then 1.6 mg twice weekly
The schedule used in a randomized trial in HBV-related acute-on-chronic liver failure: 1.6 mg daily for the first week, then twice weekly to week 12 3.
The ceiling: 1.6 mg twice weekly for maintenance; daily dosing only for acute situations under medical supervision
Reconstitution, in plain words
Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Thymosin Alpha-1:
For a typical 5mg vial, add 2.5mL of bacteriostatic water. This gives you a concentration of 2mg/mL. Each 0.8mL (80 units on an insulin syringe) equals 1.6mg—one standard dose.
At 2mg/mL concentration: draw 0.8mL (80 units) for a 1.6mg dose. If using a 3mg vial reconstituted with 1.5mL, you still get 2mg/mL and draw the same 0.8mL.
Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Thymosin Alpha-1's recorded schedule.
Injection sites & technique
Subcutaneous (under the skin) injection (just under the skin)—this is how it was used in all major clinical trials and provides reliable absorption
Timing
Morning or early afternoon injections work well for most people. Some prefer morning to align with natural cortisol (the stress hormone) rhythms and immune activity peaks.
Can be taken regardless of food. Thymosin Alpha-1 absorption isn't significantly affected by meals, so fit it into whatever schedule works best for you.
If using with other peptides like BPC-157, inject at separate sites. Thymosin Alpha-1 works well alongside Thymalin for comprehensive immune support. Space injections at least a few hours apart when stacking.
The honest list
These show up most often. They usually fade as your body adjusts.
Redness, mild swelling, or discomfort where you injected is the most frequently reported effect. It's your skin's normal response to the injection process.
What to do Rotate injection sites with each dose. Ice the area briefly if uncomfortable. These reactions typically resolve within 24-48 hours.
Worth knowing about, but most people never see these.
Some users feel a bit tired after their injection, especially in the first few doses. Your immune system is activating and that takes energy.
What to do Time your injections for when you can rest if needed. Most people find this improves after the first week as their body adjusts.
Mild muscle aches, low-grade warmth, or general 'blah' feeling in the first few doses. This is actually a sign your immune system is responding.
What to do Stay hydrated and rest. These symptoms usually fade quickly and don't return with continued dosing. If severe or persistent, reduce frequency.
A slight temperature elevation can occur as your immune system activates. This is typically low-grade and short-lived.
What to do Monitor your temperature. Mild fever (under 100.4°F) usually resolves within hours. Higher or persistent fever warrants medical attention.
You might notice your lymph nodes feel slightly enlarged or tender, especially early in treatment. This reflects increased immune activity.
What to do This is generally a sign the peptide is working. If nodes become painful or very enlarged, consult your healthcare provider.
Rare, but if any of these happen, stop and contact a medical professional.
Rare but possible with any peptide. Signs include hives, significant swelling (especially face/throat), difficulty breathing, or rapid heartbeat.
What to do STOP immediately and seek emergency medical care. Carry appropriate emergency contacts. This is extremely rare but requires immediate attention.
Week by week
Is it right for you?
Thymosin Alpha-1 is approved for specific uses in some countries but remains a research compound for other applications. Always work with a qualified healthcare provider when using any peptide therapy. This information is educational—not medical advice for your specific situation.
CONTRAINDICATED (should not be used together). Thymosin Alpha-1 stimulates immune function, directly opposing these medications. Could trigger transplant rejection.
May reduce Thymosin Alpha-1 effectiveness. If you need steroids, timing separation may help. Discuss with your doctor.
Actually studied together extensively for hepatitis. The combination shows enhanced effectiveness in clinical trials.
Research supports using Thymosin Alpha-1 alongside chemo to maintain immune function. Should be coordinated with your cancer doctor (oncologist).
Excellent pairing—both support thymus function through complementary mechanisms. Often used together in immune protocols.
Safe combination. BPC-157 focuses on healing while Thymosin Alpha-1 handles immune function—different targets, no conflict.
Can be combined for broad aging support. Epithalon targets telomeres (the protective caps on chromosomes) while Thymosin Alpha-1 supports the aging immune system.
Same family, different functions. TB-500 is for tissue repair; TA-1 is for immune function. Can be used together safely.
Excellent combination. Vitamin D also supports immune function and may enhance Thymosin Alpha-1 effects.
Safe and complementary. Zinc is essential for immune function and supports T-cell development.
Good pairing for overall immune and antioxidant support. No known interactions.
Both stimulate immunity. While likely safe, watch for signs of overstimulation if using together long-term.
Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life (how long it stays active in your body) means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Safety data come from clinical trials in hepatitis B and C, cancer and critical illness. Most studies observed only local irritation at the injection site. 4 In a 120-patient randomized trial in HBV-related acute-on-chronic liver failure, 1.6 mg was safe and improved 90-day transplant-free survival (75.0% vs 53.4%). 3 Thymalfasin is not FDA approved; it is used outside the US as Zadaxin. 6
Keeping it good
Keep lyophilized powder refrigerated at 36-46°F (2-8°C) for up to 2 years. For longer storage, freeze at -4°F (-20°C). Always store in original vial away from light. Room temperature is acceptable for short shipping periods but refrigerate upon receipt.
Refrigerate at 36-46°F (2-8°C) immediately after mixing. Never freeze reconstituted solution—ice crystals can damage the peptide. Keep away from light. Use within 14-21 days for best potency.
Not our opinion — the published record
2015
This comprehensive review showed that Thymosin Alpha-1 combined with chemotherapy improved outcomes in melanoma (a serious skin cancer) and lung cancer patients. The peptide acts on both immune cells and tumor cells, making it especially valuable as an adjunct therapy (an add-on treatment) for cancer.
Garaci E, Pica F, Matteucci C
2012
Researchers found that Thymosin Alpha-1 switches on several immune pathways through Toll-like receptors (sensors that detect germs), boosts dendritic cell function (dendritic cells show threats to T-cells), and, importantly, activates the IDO enzyme, which helps prevent harmful inflammation. This explains how it can both boost immunity AND prevent autoimmune overreaction (the immune system attacking the body).
Romani L, Moretti S, Fallarino F
2022
This randomized controlled trial of 120 patients showed that Thymosin Alpha-1 improved 90-day survival from 53% to 75% in people with severe liver failure. It also cut infection rates nearly in half and reduced the risk of hepatic encephalopathy (confusion and brain problems caused by liver failure). It is major evidence for use in serious illness.
Chen JF, Chen SR, Lei ZY
2001
This thorough review documented that Thymosin Alpha-1 cleared hepatitis B virus in 40% of treated patients versus only 9% of controls. For hepatitis C, combining it with interferon (an antiviral immune drug) achieved 65% viral clearance versus 29% with interferon alone. The 2-hour half-life (the time for half of it to leave the body) and excellent safety profile were confirmed across all trials.
Ancell CD, Phipps J, Young L
2023
This Phase 2 (mid-stage) trial in 262 dialysis patients (who are highly vulnerable to infections) tested whether Thymosin Alpha-1 could prevent COVID-19 infection. The study was completed, showing continued interest in Thymosin Alpha-1 for vulnerable groups facing infectious threats.
Clinical Trial NCT04428008
2004
Review of thymalfasin (Zadaxin, SciClone), a synthetic peptide of 28 amino acids first isolated from bovine (cow) thymus. Across seven randomized trials in chronic hepatitis B, 6 months of treatment with thymalfasin alone gave a higher virological response (less virus in the blood) than no treatment, often appearing after treatment ended.
Chien RN, Liaw YF
If this isn't the right fit
Your questions
They're from the same thymosin family but do completely different things. Thymosin Alpha-1 focuses on immune function—training and activating immune cells. Thymosin Beta-4 (TB-500) is about tissue repair, wound healing, and reducing inflammation. Think of TA-1 as the immune system coach and TB-4 as the body's repair crew. You can use them together for comprehensive support.
It's complicated. The FDA granted orphan drug status for hepatocellular carcinoma, and the synthetic version (Zadaxin/thymalfasin) is approved for certain uses. However, it's approved and widely used in over 30 other countries including China, Russia, and much of Asia for hepatitis and immune support. In the US, it's often accessed through compounding pharmacies for research purposes.
This requires careful medical supervision. While Thymosin Alpha-1 has immunomodulating properties that could theoretically help balance immune function, stimulating immunity in someone with autoimmune disease could also trigger flares. Some research suggests benefits in certain autoimmune scenarios, but this isn't something to try without close medical oversight.
Most people don't feel dramatic immediate effects—this isn't like taking a stimulant. Immune benefits typically become noticeable over weeks to months: fewer infections, faster recovery when sick, improved lab markers if you're testing. Clinical trials usually run 6-12 months to see meaningful outcomes. Think of it as gradually strengthening your defenses, not flipping a switch.
This dose (technically 900 mcg/m2 body surface area, which works out to about 1.6 mg for most adults) was established through extensive clinical trials as the sweet spot for effectiveness and safety. Higher doses didn't show better results in studies, and this dose has decades of safety data. It's one of the most studied peptide doses in existence.
Unlike some peptides, Thymosin Alpha-1 has been used continuously for extended periods in clinical settings—some hepatitis trials ran 12+ months. That said, many people do cycle (8-12 weeks on, 4-8 weeks off) for general immune maintenance. Discuss with your provider what makes sense for your specific goals. There's no evidence of tolerance or reduced effectiveness with longer use.
Thymosin Alpha-1 enhances your immune system's ability to respond to threats—it doesn't create a magic shield. Users often report fewer infections and faster recovery, but you can still catch viruses and bacteria. Think of it as improving your odds and reducing severity, not providing immunity. It's particularly valuable for people whose immune systems need extra support.
No—those are very different. Oral thymus glandular supplements are crude extracts that mostly get digested before they can do anything. Thymosin Alpha-1 is a specific, pure 28-amino-acid peptide sequence that's injected to bypass digestion and ensure it reaches your immune system intact. The precision and delivery method make a huge difference in effectiveness.
6 sources
Every numbered marker on this page points to one of these. Same sources, same numbering as the Thymosin Alpha-1 research profile on Peptide Initiative.
Want the deep science?
Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.
Open the research profileThis guide is education, not medical advice. Thymosin Alpha-1 is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.
PeptideGeek